BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 33964913)

  • 1. Poor prognosis of male triple-positive breast Cancer patients: a propensity score matched SEER analysis and molecular portraits.
    Wang B; Wang H; Zhao A; Zhang M; Yang J
    BMC Cancer; 2021 May; 21(1):523. PubMed ID: 33964913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone Receptor-Positive Breast Cancer Has a Worse Prognosis in Male Than in Female Patients.
    Li X; Yang J; Krishnamurti U; Huo L; Ward KC; O'Regan R; Peng L
    Clin Breast Cancer; 2017 Aug; 17(5):356-366. PubMed ID: 28576631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Men and women show similar survival outcome in stage IV breast cancer.
    Wu SG; Zhang WW; Liao XL; Sun JY; Li FY; Su JJ; He ZY
    Breast; 2017 Aug; 34():115-121. PubMed ID: 28577471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathologic characteristics and survival of male breast cancer.
    Liu D; Xie G; Chen M
    Int J Clin Oncol; 2014 Apr; 19(2):280-7. PubMed ID: 23640121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overall Survival of Men and Women With Breast Cancer According to Tumor Subtype: A Population-based Study.
    Leone J; Zwenger AO; Leone BA; Vallejo CT; Leone JP
    Am J Clin Oncol; 2019 Feb; 42(2):215-220. PubMed ID: 30499840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of male breast cancer in the United States: a surveillance, epidemiology and end results analysis.
    Fields EC; DeWitt P; Fisher CM; Rabinovitch R
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):747-52. PubMed ID: 24138917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathologic characteristics and prognosis for male breast cancer compared to female breast cancer.
    Yao N; Shi W; Liu T; Siyin ST; Wang W; Duan N; Xu G; Qu J
    Sci Rep; 2022 Jan; 12(1):220. PubMed ID: 34997151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment Outcomes and Prognostic Factors in Male Patients With Stage IV Breast Cancer: A Population-based Study.
    Chen W; Huang Y; Lewis GD; Szeja SS; Hatch SS; Farach A; Miltenburg D; Butler EB; Chang JC; Teh BS
    Clin Breast Cancer; 2018 Feb; 18(1):e97-e105. PubMed ID: 28888581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poorer breast cancer survival outcomes in males than females might be attributable to tumor subtype.
    Wu Q; Li J; Zhu S; Wu J; Li X; Liu Q; Wei W; Sun S
    Oncotarget; 2016 Dec; 7(52):87532-87542. PubMed ID: 27655704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Prognostic Analysis of Male Breast Cancer (MBC) Compared with Post-Menopausal Female Breast Cancer (FBC).
    Yu XF; Yang HJ; Yu Y; Zou DH; Miao LL
    PLoS One; 2015; 10(8):e0136670. PubMed ID: 26313461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis on the clinical and prognostic features of 71 male patients with breast cancer].
    Liu DY; Xie GR; Chen M
    Zhonghua Liu Xing Bing Xue Za Zhi; 2013 Feb; 34(2):187-90. PubMed ID: 23751479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chinese female breast cancer patients show a better overall survival than their male counterparts.
    Xia LP; Zhou FF; Guo GF; Wang F; Wang X; Yuan ZY; Zhang B
    Chin Med J (Engl); 2010 Sep; 123(17):2347-52. PubMed ID: 21034547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Male breast cancer in the veterans affairs population: a comparative analysis.
    Nahleh ZA; Srikantiah R; Safa M; Jazieh AR; Muhleman A; Komrokji R
    Cancer; 2007 Apr; 109(8):1471-7. PubMed ID: 17342768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Male breast cancer: A closer look at patient and tumor characteristics and factors associated with survival.
    Zhao J; Wang B; Zhao J; Mao Y; Liu J; Yang Y
    Thorac Cancer; 2020 Nov; 11(11):3107-3116. PubMed ID: 32930510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Male breast cancer: Looking for better prognostic subgroups.
    Abreu MH; Afonso N; Abreu PH; Menezes F; Lopes P; Henrique R; Pereira D; Lopes C
    Breast; 2016 Apr; 26():18-24. PubMed ID: 27017238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early and Locally Advanced Metaplastic Breast Cancer: Presentation and Survival by Receptor Status in Surveillance, Epidemiology, and End Results (SEER) 2010-2014.
    Schroeder MC; Rastogi P; Geyer CE; Miller LD; Thomas A
    Oncologist; 2018 Apr; 23(4):481-488. PubMed ID: 29330212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone receptor-positive breast cancer and black race: does sex matter?
    Eskander MF; Li Y; Bhattacharyya O; Tsung A; Oppong BA; Hamad A; Gatti-Mays M; Obeng-Gyasi S
    Breast Cancer Res Treat; 2021 Nov; 190(1):111-119. PubMed ID: 34383180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic significance of molecular subtype for male breast cancer: a 10-year retrospective study.
    Yu XF; Feng WL; Miao LL; Chen B; Yang HJ
    Breast; 2013 Oct; 22(5):824-7. PubMed ID: 23466329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between male and female breast cancer survival using propensity score matching analysis.
    Scomersi S; Giudici F; Cacciatore G; Losurdo P; Fracon S; Cortinovis S; Ceccherini R; Zanconati F; Tonutti M; Bortul M
    Sci Rep; 2021 Jun; 11(1):11639. PubMed ID: 34079019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and survival outcomes of early male breast cancer: a population-based comparison with early female breast cancer.
    Wang Y; Chen K; Yang Y; Tan L; Chen L; Zhu L; Su F; Liu X; Li S
    Ann Transl Med; 2019 Oct; 7(20):536. PubMed ID: 31807518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.